Insights into organelle forming RNAs: Diversity, functions and future perspectives

Meng Gong , Xiangting Wang , Xiaolin Liang

Animal Models and Experimental Medicine ›› 2025, Vol. 8 ›› Issue (12) : 2187 -2195.

PDF (2947KB)
Animal Models and Experimental Medicine ›› 2025, Vol. 8 ›› Issue (12) :2187 -2195. DOI: 10.1002/ame2.70080
REVIEW
Insights into organelle forming RNAs: Diversity, functions and future perspectives
Author information +
History +
PDF (2947KB)

Abstract

RNA molecules play diverse and essential roles in cellular processes beyond their well-known functions in gene expression and regulation. While ribosomal RNAs (rRNAs) have long been recognized as structural components of ribosomes, recent research has highlighted the importance of a distinct group of RNAs which directly compose the structures or organelles in mammalian cells. We refer to these as ‘organelle formation RNAs’. Specifically, the discovery of tubulin-associated lncRNA (TubAR), the first identified cytoskeleton-forming RNA, has expanded our understanding of RNA functionality; we now recognize ‘organelle formation RNAs’ not only as regulatory molecules but also as direct structural components within cellular subunits. Other ‘organelle formation RNAs’ include paraspeckle-forming RNAs, nuclear speckle-forming RNAs, and nucleolus-forming RNAs. Various RNAs contribute to the formation of distinct cellular structures, while also participating in intricate intermolecular interactions. Understanding these molecules not only uncovers their fundamental roles in cellular physiology but also suggests potential applications in the treatment of related diseases. By examining the latest advancements and methodologies in organelle formation RNA research, this review provides a comprehensive overview of the intricate mechanisms of these RNAs and future directions in the field.

Keywords

non-coding RNAs / organelle formation RNAs / TubAR / LoNA / NEAT1 / MALAT1

Cite this article

Download citation ▾
Meng Gong, Xiangting Wang, Xiaolin Liang. Insights into organelle forming RNAs: Diversity, functions and future perspectives. Animal Models and Experimental Medicine, 2025, 8 (12) : 2187-2195 DOI:10.1002/ame2.70080

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Harris T. Evidence for RNA origins. Nature. 2010; 464: 494.

[2]

Crick F. Central dogma of molecular biology. Nature. 1970; 227: 561-563.

[3]

Hori Y, Engel C, Kobayashi T. Regulation of ribosomal RNA gene copy number, transcription and nucleolus organization in eukaryotes. Nat Rev Mol Cell Biol. 2023; 24: 414-429.

[4]

Wang YH, Dai H, Zhang L, et al. Cryo-electron microscopy structure and translocation mechanism of the crenarchaeal ribosome. Nucleic Acids Res. 2023; 51: 8909-8924.

[5]

Hafner SJ, Jansson MD, Altinel K, et al. Ribosomal RNA 2'-O-methylation dynamics impact cell fate decisions. Dev Cell. 2023; 58(1593–1609):e1599.

[6]

Opron K, Burton ZF. Ribosome structure, function, and early evolution. Int J Mol Sci. 2018; 20:40.

[7]

Naganuma T, Nakagawa S, Tanigawa A, Sasaki YF, Goshima N, Hirose T. Alternative 3′-end processing of long noncoding RNA initiates construction of nuclear paraspeckles. EMBO J. 2012; 31: 4020-4034.

[8]

Yamazaki T, Souquere S, Chujo T, et al. Functional domains of NEAT1 architectural lncRNA induce paraspeckle assembly through phase separation. Mol Cell. 2018; 70: 1038-1053.e7.

[9]

Hutchinson JN, Ensminger AW, Clemson CM, Lynch CR, Lawrence JB, Chess A. A screen for nuclear transcripts identifies two linked noncoding RNAs associated with SC35 splicing domains. BMC Genomics. 2007; 8:39.

[10]

Zhang Z, Lieberman J. MALAT1 protects dormant tumor cells from immune elimination. Nat Cancer. 2024; 5: 218-220.

[11]

Gutschner T, Hammerle M, Diederichs S. MALAT1 -- a paradigm for long noncoding RNA function in cancer. J Mol Med (Berl). 2013; 91: 791-801.

[12]

Li D, Cao R, Li Q, et al. Nucleolus assembly impairment leads to two-cell transcriptional repression via NPM1-mediated PRC2 recruitment. Nat Struct Mol Biol. 2023; 30: 914-925.

[13]

Li D, Zhang J, Wang M, et al. Activity dependent LoNA regulates translation by coordinating rRNA transcription and methylation. Nat Commun. 2018; 9:1726.

[14]

Liang X, Gong M, Wang Z, et al. LncRNA TubAR complexes with TUBB4A and TUBA1A to promote microtubule assembly and maintain myelination. Cell Discov. 2024; 10: 54.

[15]

Rinn JL, Chang HY. Genome regulation by long noncoding RNAs. Annu Rev Biochem. 2012; 81: 145-166.

[16]

Lyu Y, Bai L, Qin C. Long noncoding RNAs in neurodevelopment and Parkinson's disease. Animal Model Exp Med. 2019; 2: 239-251.

[17]

Liang X, Wang X. LncRNAs: current understanding, future directions, and challenges. Animal Model Exp Med. 2023; 6: 505-507.

[18]

Statello L, Guo CJ, Chen LL, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021; 22: 96-118.

[19]

Sharifi S, Chaudhari P, Martirosyan A, et al. Reducing the metabolic burden of rRNA synthesis promotes healthy longevity in Caenorhabditis elegans. Nat Commun. 2024; 15: 1702.

[20]

Aubert M, O'Donohue MF, Lebaron S, Gleizes PE. Pre-ribosomal RNA processing in human cells: from mechanisms to congenital diseases. Biomolecules. 2018; 8:123.

[21]

Lafontaine DL, Tollervey D. The function and synthesis of ribosomes. Nat Rev Mol Cell Biol. 2001; 2: 514-520.

[22]

Albert B, Perez-Fernandez J, Leger-Silvestre I, Gadal O. Regulation of ribosomal RNA production by RNA polymerase I: does elongation come first? Genet Res Int. 2012; 2012:276948.

[23]

Chaillou T, Kirby TJ, McCarthy JJ. Ribosome biogenesis: emerging evidence for a central role in the regulation of skeletal muscle mass. J Cell Physiol. 2014; 229: 1584-1594.

[24]

Mitterer V, Pertschy B. RNA folding and functions of RNA helicases in ribosome biogenesis. RNA Biol. 2022; 19: 781-810.

[25]

Shen H, Stoute J, Liu KF. Structural and catalytic roles of the human 18S rRNA methyltransferases DIMT1 in ribosome assembly and translation. J Biol Chem. 2020; 295: 12058-12070.

[26]

Peng H, Chen B, Wei W, et al. N(6)-methyladenosine (m(6)a) in 18S rRNA promotes fatty acid metabolism and oncogenic transformation. Nat Metab. 2022; 4: 1041-1054.

[27]

Pinto R, Vagbo CB, Jakobsson ME, et al. The human methyltransferase ZCCHC4 catalyses N6-methyladenosine modification of 28S ribosomal RNA. Nucleic Acids Res. 2020; 48: 830-846.

[28]

Chen J, Bai Y, Huang Y, et al. The Ptch/SPOUT1 methyltransferase deposits an m(3)U modification on 28S rRNA for normal ribosomal function in flies and humans. Sci Adv. 2024; 10: eadr1743.

[29]

Heissenberger C, Liendl L, Nagelreiter F, et al. Loss of the ribosomal RNA methyltransferase NSUN5 impairs global protein synthesis and normal growth. Nucleic Acids Res. 2019; 47: 11807-11825.

[30]

Abou Elela S, Nazar RN. Role of the 5.8S rRNA in ribosome translocation. Nucleic Acids Res. 1997; 25: 1788-1794.

[31]

Pfeffer S, Dudek J, Zimmermann R, Forster F. Organization of the native ribosome-translocon complex at the mammalian endoplasmic reticulum membrane. Biochim Biophys Acta. 2016; 1860: 2122-2129.

[32]

Huang S, Aleksashin NA, Loveland AB, et al. Ribosome engineering reveals the importance of 5S rRNA autonomy for ribosome assembly. Nat Commun. 2020; 11: 2900.

[33]

Jackson RJ, Hellen CU, Pestova TV. The mechanism of eukaryotic translation initiation and principles of its regulation. Nat Rev Mol Cell Biol. 2010; 11: 113-127.

[34]

Brito Querido J, Diaz-Lopez I, Ramakrishnan V. The molecular basis of translation initiation and its regulation in eukaryotes. Nat Rev Mol Cell Biol. 2024; 25: 168-186.

[35]

Noller HF. The ribosome comes to life. Cell. 2024; 187: 6486-6500.

[36]

Xu B, Liu L, Song G. Functions and regulation of translation elongation factors. Front Mol Biosci. 2021; 8:816398.

[37]

Lareau LF, Hite DH, Hogan GJ, Brown PO. Distinct stages of the translation elongation cycle revealed by sequencing ribosome-protected mRNA fragments. elife. 2014; 3:e01257.

[38]

Guru SC, Agarwal SK, Manickam P, et al. A transcript map for the 2.8-mb region containing the multiple endocrine neoplasia type 1 locus. Genome Res. 1997; 7: 725-735.

[39]

Taiana E, Ronchetti D, Todoerti K, et al. LncRNA NEAT1 in paraspeckles: a structural scaffold for cellular DNA damage response systems? Noncoding RNA. 2020; 6:26.

[40]

Skeparnias I, Zhang J. Structural basis of NEAT1 lncRNA maturation and menRNA instability. Nat Struct Mol Biol. 2024; 31: 1650-1654.

[41]

Zakutansky PM, Ku L, Zhang G, et al. Isoform balance of the long noncoding RNA NEAT1 is regulated by the RNA-binding protein QKI, governs the glioma transcriptome, and impacts cell migration. J Biol Chem. 2024; 300:107595.

[42]

Luo X, Wei Q, Jiang X, et al. CSTF3 contributes to platinum resistance in ovarian cancer through alternative polyadenylation of lncRNA NEAT1 and generating the short isoform NEAT1_1. Cell Death Dis. 2024; 15: 432.

[43]

Fox AH, Nakagawa S, Hirose T, Bond CS. Paraspeckles: where long noncoding RNA meets phase separation. Trends Biochem Sci. 2018; 43: 124-135.

[44]

McCluggage F, Fox AH. Paraspeckle nuclear condensates: global sensors of cell stress? Bioessays. 2021; 43:e2000245.

[45]

Zhen S, Jia Y, Zhao Y, et al. NEAT1_1 confers gefitinib resistance in lung adenocarcinoma through promoting AKR1C1-mediated ferroptosis defence. Cell Death Dis. 2024; 10: 131.

[46]

Wang C, Duan Y, Duan G, et al. Stress induces dynamic, cytotoxicity-antagonizing TDP-43 nuclear bodies via paraspeckle LncRNA NEAT1-mediated liquid-liquid phase separation. Mol Cell. 2020; 79: 443-458.e7.

[47]

Kukharsky MS, Ninkina NN, An H, et al. Long non-coding RNA Neat1 regulates adaptive behavioural response to stress in mice. Transl Psychiatry. 2020; 10: 171.

[48]

Boros FA, Vecsei L, Klivenyi P. NEAT1 on the field of Parkinson's disease: offense, defense, or a player on the bench? J Parkinsons Dis. 2021; 11: 123-138.

[49]

Ma T, Li H, Liu H, et al. Neat1 promotes acute kidney injury to chronic kidney disease by facilitating tubular epithelial cells apoptosis via sequestering miR-129-5p. Mol Ther. 2022; 30: 3313-3332.

[50]

Park MK, Zhang L, Min KW, et al. NEAT1 is essential for metabolic changes that promote breast cancer growth and metastasis. Cell Metab. 2021; 33: 2380-2397.e9.

[51]

Standaert L, Adriaens C, Radaelli E, et al. The long noncoding RNA Neat1 is required for mammary gland development and lactation. RNA. 2014; 20: 1844-1849.

[52]

Ji P, Diederichs S, Wang W, et al. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene. 2003; 22: 8031-8041.

[53]

Bejerano G, Pheasant M, Makunin I, et al. Ultraconserved elements in the human genome. Science. 2004; 304: 1321-1325.

[54]

Djebali S, Davis CA, Merkel A, et al. Landscape of transcription in human cells. Nature. 2012; 489: 101-108.

[55]

Skeparnias I, Bou-Nader C, Anastasakis DG, et al. Structural basis of MALAT1 RNA maturation and mascRNA biogenesis. Nat Struct Mol Biol. 2024; 31: 1655-1668.

[56]

Miao H, Wu F, Li Y, et al. MALAT1 modulates alternative splicing by cooperating with the splicing factors PTBP1 and PSF. Sci Adv. 2022; 8: eabq7289.

[57]

Luan N, Wang J, Sheng B, et al. tRF-20-M0NK5Y93-induced MALAT1 promotes colon cancer metastasis through alternative splicing of SMC1A. Am J Cancer Res. 2023; 13: 852-871.

[58]

Wang X, Liu C, Zhang S, et al. N(6)-methyladenosine modification of MALAT1 promotes metastasis via reshaping nuclear speckles. Dev Cell. 2021; 56: 702-715.e8.

[59]

Tripathi V, Ellis JD, Shen Z, et al. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol Cell. 2010; 39: 925-938.

[60]

Zhang B, Arun G, Mao YS, et al. The lncRNA Malat1 is dispensable for mouse development but its transcription plays a cis-regulatory role in the adult. Cell Rep. 2012; 2: 111-123.

[61]

Onoguchi-Mizutani R, Kirikae Y, Ogura Y, Gutschner T, Diederichs S, Akimitsu N. Identification of a heat-inducible novel nuclear body containing the long noncoding RNA MALAT1. J Cell Sci. 2021; 134(10):jcs253559. Epub 2021 May 24. PMID: 34028540.

[62]

Cho SF, Chang WH, Liao WT, et al. Targeting Druggabble long non-coding RNA MALAT1: epigenetic regulation of CD38 and energy metabolism in multiple myeloma. Blood. 2024; 144: 6839.

[63]

Lafontaine DLJ, Riback JA, Bascetin R, Brangwynne CP. The nucleolus as a multiphase liquid condensate. Nat Rev Mol Cell Biol. 2021; 22: 165-182.

[64]

Wu M, Xu G, Han C, et al. lncRNA SLERT controls phase separation of FC/DFCs to facilitate pol I transcription. Science. 2021; 373: 547-555.

[65]

Shan L, Xu G, Yao RW, et al. Nucleolar URB1 ensures 3' ETS rRNA removal to prevent exosome surveillance. Nature. 2023; 615: 526-534.

[66]

Drygin D, Rice WG, Grummt I. The RNA polymerase I transcription machinery: an emerging target for the treatment of cancer. Annu Rev Pharmacol Toxicol. 2010; 50: 131-156.

[67]

Metge BJ, Kammerud SC, Pruitt HC, Shevde LA, Samant RS. Hypoxia re-programs 2'-O-me modifications on ribosomal RNA. iScience. 2021; 24:102010.

[68]

Fulka H, Aoki F. Nucleolus precursor bodies and ribosome biogenesis in early mammalian embryos: old theories and new discoveries. Biol Reprod. 2016; 94: 143.

[69]

Borisy G, Heald R, Howard J, Janke C, Musacchio A, Nogales E. Microtubules: 50 years on from the discovery of tubulin. Nat Rev Mol Cell Biol. 2016; 17: 322-328.

[70]

Blower MD, Nachury M, Heald R, Weis K. A Rae1-containing ribonucleoprotein complex is required for mitotic spindle assembly. Cell. 2005; 121: 223-234.

[71]

Hussain S, Benavente SB, Nascimento E, et al. The nucleolar RNA methyltransferase Misu (NSun2) is required for mitotic spindle stability. J Cell Biol. 2009; 186: 27-40.

[72]

Ito KK, Watanabe K, Kitagawa D. The emerging role of ncRNAs and RNA-binding proteins in mitotic apparatus formation. Noncoding RNA. 2020; 6:13.

[73]

Alliegro MC. The centrosome and spindle as a ribonucleoprotein complex. Chromosom Res. 2011; 19: 367-376.

[74]

Huang Z, Zhao J, Wang W, Zhou J, Zhang J. Depletion of LncRNA NEAT1 rescues mitochondrial dysfunction through NEDD4L-dependent PINK1 degradation in animal models of Alzheimer's disease. Front Cell Neurosci. 2020; 14:28.

[75]

Irwin A, Martina V, Bahabry R, Stuckey R, Lubin F. The long non-coding RNA Neat1 contributes to memory deficits in aging and Alzheimer's disease (P7-9.011). Neurology. 2024; 102: 6159.

[76]

Dong L, Zheng Y, Luo X. lncRNA NEAT1 promotes autophagy of neurons in mice by impairing miR-107-5p. Bioengineered. 2022; 13: 12261-12274.

[77]

Chen R, Zhang Y, Shen Y, Wu K, Mo X, Yang Z. LncRNA NEAT1, an important biomarker involved in the pathological and physiological processes of Parkinson's disease. J Neuroimmune Pharmacol. 2025; 20: 7.

[78]

Mello SS, Sinow C, Raj N, et al. Neat1 is a p53-inducible lincRNA essential for transformation suppression. Genes Dev. 2017; 31: 1095-1108.

[79]

Martin L, Kamstra JH, Hurem S, et al. Altered non-coding RNA expression profile in F(1) progeny 1 year after parental irradiation is linked to adverse effects in zebrafish. Sci Rep. 2021; 11: 4142.

[80]

Liu JY, Yao J, Li XM, et al. Pathogenic role of lncRNA-MALAT1 in endothelial cell dysfunction in diabetes mellitus. Cell Death Dis. 2014; 5:e1506.

[81]

Kumar D, Gurrapu S, Wang Y, et al. LncRNA Malat1 suppresses pyroptosis and T cell-mediated killing of incipient metastatic cells. Nat Cancer. 2024; 5: 262-282.

[82]

Zhang C, Qin Y, Wu Y, Xu H, Shu Y. Long non-coding RNA MALAT1 in hematological malignancies and its clinical applications. Chin Med J. 2024; 137: 1151-1159.

[83]

Wang L, Fu G, Han R, et al. MALAT1 and NEAT1 are neuroprotective during hypoxic preconditioning in the mouse hippocampus possibly by regulation of NR2B. High Alt Med Biol. 2024; 25: 285-294.

[84]

Zhang C, Lu YJ, Wang M, et al. Characterisation of APOBEC3B-mediated RNA editing in breast cancer cells reveals regulatory roles of NEAT1 and MALAT1 lncRNAs. Oncogene. 2024; 43: 3366-3377.

[85]

Bassler J, Hurt E. Eukaryotic ribosome assembly. Annu Rev Biochem. 2019; 88: 281-306.

[86]

Ma H, Jia X, Zhang K, Su Z. Cryo-EM advances in RNA structure determination. Signal Transduct Target Ther. 2022; 7: 58.

RIGHTS & PERMISSIONS

2025 The Author(s). Animal Models and Experimental Medicine published by John Wiley & Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences.

PDF (2947KB)

1

Accesses

0

Citation

Detail

Sections
Recommended

/